NEW YORK, March 29, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of DS Healthcare Group, Inc. (“DS Healthcare”) (NASDAQ:DSKX) between August 13, 2015 and March 23, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired DS Healthcare securities between August 13, 2015 and March 23, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/ds-healthcare-group.
On March 23, 2016, DS Healthcare revealed that its financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015 were found to have revenue recognition errors and improper recording of certain equity. The Company also announced that the Audit Committee and independent counsel had initiated an investigation in connection with the company’s President, Daniel Khesin, for allegedly fraudulent revenue recognition and equity transaction errors, and that Mr. Khesin had been dismissed. Then on March 29, 2016, the Company announced that the Audit Committee determined the errors totaled approximately $900,000 in reduced revenues, and that as a result, estimated unaudited 2015 fiscal year revenues should be reduced by approximately 6 percent.
If you suffered a loss in DS Healthcare you have until May 31, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/ds-healthcare-group.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



